Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About Yandex NV (YNDX) Anymore

Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds and investors’ positions as of the end of the third quarter. You can find write-ups about an individual hedge fund’s trades on numerous financial news websites. However, in this article we will take a look at their collective moves and analyze what the smart money thinks of Yandex NV (NASDAQ:YNDX) based on that data.

Is Yandex NV (NASDAQ:YNDX) ready to rally soon? Prominent investors are in a pessimistic mood. The number of long hedge fund positions were trimmed by 1 recently. Our calculations also showed that YNDX isn’t among the 30 most popular stocks among hedge funds.

So, why do we pay attention to hedge fund sentiment before making any investment decisions? Our research has shown that hedge funds’ small-cap stock picks managed to the beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the market by 18 percentage points since May 2014 through December 3, 2018 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter. Even if you aren’t comfortable with shorting stocks, you should at least avoid initiating long positions in our short portfolio.

Gabriel Plotkin Melvin Capital Management

We’re going to analyze the latest hedge fund action surrounding Yandex NV (NASDAQ:YNDX).

How have hedgies been trading Yandex NV (NASDAQ:YNDX)?

At Q3’s end, a total of 37 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -3% from the second quarter of 2018. By comparison, 44 hedge funds held shares or bullish call options in YNDX heading into this year. With hedge funds’ sentiment swirling, there exists a few noteworthy hedge fund managers who were adding to their holdings substantially (or already accumulated large positions).

YNDX_dec2018

Among these funds, Sachem Head Capital held the most valuable stake in Yandex NV (NASDAQ:YNDX), which was worth $142.6 million at the end of the third quarter. On the second spot was Cadian Capital which amassed $133.1 million worth of shares. Moreover, Light Street Capital, OZ Management, and Melvin Capital Management were also bullish on Yandex NV (NASDAQ:YNDX), allocating a large percentage of their portfolios to this stock.

Due to the fact that Yandex NV (NASDAQ:YNDX) has witnessed declining sentiment from the aggregate hedge fund industry, we can see that there exists a select few funds that decided to sell off their positions entirely by the end of the third quarter. Intriguingly, Robert Boucai’s Newbrook Capital Advisors dumped the biggest investment of the “upper crust” of funds tracked by Insider Monkey, comprising an estimated $109.1 million in call options. Gabriel Plotkin’s fund, Melvin Capital Management, also dropped its call options, about $108.5 million worth. These transactions are interesting, as total hedge fund interest dropped by 1 funds by the end of the third quarter.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as Yandex NV (NASDAQ:YNDX) but similarly valued. We will take a look at Westlake Chemical Corporation (NYSE:WLK), PerkinElmer, Inc. (NYSE:PKI), Cboe Global Markets, Inc. (NASDAQ:CBOE), and Sarepta Therapeutics Inc (NASDAQ:SRPT). This group of stocks’ market valuations resemble YNDX’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
WLK 19 326824 -5
PKI 23 1117448 1
CBOE 21 804776 -6
SRPT 43 1213313 -4

View table here if you experience formatting issues.

As you can see these stocks had an average of 26.5 hedge funds with bullish positions and the average amount invested in these stocks was $866 million. That figure was $985 million in YNDX’s case. Sarepta Therapeutics Inc (NASDAQ:SRPT) is the most popular stock in this table. On the other hand Westlake Chemical Corporation (NYSE:WLK) is the least popular one with only 19 bullish hedge fund positions. Yandex NV (NASDAQ:YNDX) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard SRPT might be a better candidate to consider a long position.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...